[1] |
Sprung CL,Peduzzi PN,Shatney CH, et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group [J]. Crit Care Med, 1990, 18(8): 801-806.
|
[2] |
Zhang LN,Wang XT,Ai YH, et al. Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011 [J]. Chin Med J (Engl), 2012, 125(5): 828-831.
|
[3] |
Wang H,Bloom O,Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice [J]. Science, 1999, 285(5425): 248-251.
|
[4] |
Yang R,Zhu S,Tonnessen TI. Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries [J]. J Inflamm (Lond), 2016, 13: 37.
|
[5] |
Rittirsch D,Huber-Lang MS,Flierl MA, et al. Immunodesign of experimental sepsis by cecal ligation and puncture [J]. Nat Protoc, 2009, 4(1): 31-36.
|
[6] |
Paxinos G,Watson C. The rat brain in stereotaxic coordinates - the new coronal set [M]. Fifth Edition. Elsevier: 2004.
|
[7] |
Relja B,Wagner N,Franz N, et al. Ethyl pyruvate reduces acute lung damage following trauma and hemorrhagic shock via inhibition of NF-kappaB and HMGB1 [J]. Immunobiology, 2018, 223(3): 310-318.
|
[8] |
Soh S,Jun JH,Song JW, et al. Ethyl pyruvate attenuates myocardial ischemia-reperfusion injury exacerbated by hyperglycemia via retained inhibitory effect on HMGB1 [J]. Int J Cardiol, 2018, 252: 156-162.
|
[9] |
Wagner N,Dieteren S,Franz N, et al. Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release [J]. PLoS One, 2018, 13(2): e192171.
|
[10] |
Jung SM,Lee J,Baek SY, et al. Ethyl pyruvate ameliorates inflammatory arthritis in mice [J]. Int Immunopharmacol, 2017, 52: 333-341.
|
[11] |
Li W,Lou J,Wei L, et al. Ethyl pyruvate protects PC12 cells from oxygen-glucose deprivation: A potential role in ischemic cerebrovascular disease [J]. Biomed Pharmacother, 2017, 92: 168-174.
|
[12] |
Lv T,Miao YF,Jin YC, et al. Ethyl pyruvate attenuates early brain injury following subarachnoid hemorrhage in the endovascular perforation rabbit model possibly via anti-inflammation and inhibition of jnk signaling pathway [J]. Neurochem Res, 2017, 42(4): 1044-1056.
|
[13] |
Reinhart K,Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned [J]. Crit Care Med, 2001, 29(7 Suppl): S121-S125.
|
[14] |
Tracey KJ,Fong Y,Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia [J]. Nature, 1987, 330(6149): 662-664.
|
[15] |
Gibot S,Massin F,Cravoisy A, et al. High-mobility group box 1 protein plasma concentrations during septic shock [J]. Intensive Care Med, 2007, 33(8): 1347-1353.
|
[16] |
He HJ,Wang Y,Le Y, et al. Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats [J]. CNS Neurosci Ther, 2012, 18(12): 994-1002.
|
[17] |
Takata K,Takada T,Ito A, et al. Microglial Amyloid-beta1-40 Phagocytosis Dysfunction Is Caused by High-Mobility Group Box Protein-1: Implications for the Pathological Progression of Alzheimer′s Disease [J]. Int J Alzheimers Dis, 2012, 2012: 685739.
|
[18] |
Takata K,Kitamura Y,Tsuchiya D, et al. High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity [J]. J Neurosci Res, 2004, 78(6): 880-891.
|
[19] |
Han Y,Englert JA,Yang R, et al. Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65 [J]. J Pharmacol Exp Ther, 2005, 312(3): 1097-1105.
|
[20] |
Luan ZG,Zhang J,Yin XH, et al. Ethyl pyruvate significantly inhibits tumour necrosis factor-alpha, interleukin-1beta and high mobility group box 1 releasing and attenuates sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury [J]. Clin Exp Immunol, 2013, 172(3): 417-426.
|